Literature DB >> 26960266

Geographical access to radiation therapy in North Queensland: a retrospective analysis of patient travel to radiation therapy before and after the opening of an additional radiotherapy facility.

Divya K Sharma1, Venkat N Vangaveti2, Sarah Larkins3.   

Abstract

INTRODUCTION: Access to radiation therapy (RT) underlies optimal care for prostate and breast cancer patients. This study investigates the impact of opening a new RT clinic on distance and road travel time to RT, and overall utilisation for prostate and breast cancer patients over a 3-year period in North Queensland (NQ), Australia.
METHODS: The study used retrospective audit of two radiotherapy databases and a geographic information system to illustrate patient origins and distance to the RT clinic used over 3 years. Prostate and female breast cancer patients were selected from the radiation oncology databases of The Townsville Hospital (TTH) and Radiation Oncology Queensland (ROQ) Cairns between 1 July 2010 and 30 June 2013. Distance from a patient's home origin to the RT facility was mapped using a geographic information system (ArcGIS software), and travel time (minutes) and road distance (km) determined by Google Maps road directions.
RESULTS: Overall number of prostate and breast cancer patients treated by RT in Cairns and Townsville clinics increased by 16% in 2011-2012 and by 29% in 2012-2013 from year 1 values. In 2010, 44% of the patients travelled 200-400 km to RT, which reduced to 21% in 2013. By 2013, with a second treatment facility, more than 70% of patients lived within 200 km of an RT facility (p<0.0001). Total median road travel time reduced annually from 201 minutes in 2010-2011 to 66 minutes in 2011-2012 and 56 minutes in 2012-2013 (p<0.0001), corresponding to a decrease in the median distance travelled to an RT facility.
CONCLUSIONS: An additional RT facility in NQ has led to an increase in patients treated with RT for prostate and breast cancer and, on average, less travel distance and time to treatment, suggesting improvement in access to RT in NQ.

Entities:  

Keywords:  Allied Health; Australia/Pacific; Cancer; Epidemiology; Health Needs Assessment; Medical

Mesh:

Year:  2016        PMID: 26960266

Source DB:  PubMed          Journal:  Rural Remote Health        ISSN: 1445-6354            Impact factor:   1.759


  6 in total

1.  Changes to radiotherapy utilisation in Western NSW after the opening of a local service.

Authors:  Sally M Butler
Journal:  J Med Radiat Sci       Date:  2017-02-03

2.  An Exploration of Underrepresentation of Aboriginal Cancer Patients Attending a Regional Radiotherapy Service in Western Australia.

Authors:  Marilyn Lyford; Margaret M Haigh; Siddhartha Baxi; Shelley Cheetham; Shaouli Shahid; Sandra C Thompson
Journal:  Int J Environ Res Public Health       Date:  2018-02-14       Impact factor: 3.390

3.  A cross-sectional ecological analysis of international and sub-national health inequalities in commercial geospatial resource availability.

Authors:  Winfred Dotse-Gborgbortsi; Nicola Wardrop; Ademola Adewole; Mair L H Thomas; Jim Wright
Journal:  Int J Health Geogr       Date:  2018-05-23       Impact factor: 3.918

4.  Variations in outcomes by residential location for women with breast cancer: a systematic review.

Authors:  Paramita Dasgupta; Peter D Baade; Danny R Youlden; Gail Garvey; Joanne F Aitken; Isabella Wallington; Jennifer Chynoweth; Helen Zorbas; Philippa H Youl
Journal:  BMJ Open       Date:  2018-04-29       Impact factor: 2.692

5.  Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction.

Authors:  Elizabeth Hamilton; Ellie Van Veldhuizen; Amy Brown; Sean Brennan; Sabe Sabesan
Journal:  Clin Transl Radiat Oncol       Date:  2018-11-20

6.  How many roads must a Malaysian walk down? Mapping the accessibility of radiotherapy facilities in Malaysia.

Authors:  Noorazrul Yahya; Nur Khalis Sukiman; Nani Adilah Suhaimi; Nor Aniza Azmi; Hanani A Manan
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.